Results 11 to 20 of about 2,820,921 (304)

Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae, [PDF]

Anais Brasileiros de Dermatologia, 2020
The authors report a rare case of primary cutaneous mucormycosis caused by Mucor irregularis and cutaneous Klebsiella pneumoniae infections in a 67-year-old Chinese woman.
Siping Zhang, Kunju Zhu, Chi Zhang
doaj   +1 more source

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine

JAAD Case Reports, 2021
AGEP: acute generalized exanthematous pustulosis DRESS: drug reaction with eosinophilia and systemic symptoms SCAR: severe cutaneous adverse reaction INTRODUCTION On 21 January 2021, an interim analysis of a phase-3 clinical trial revealed that the ...
Kristen Lospinoso, C. Nichols, Stephen J. Malachowski, M. Mochel, Fnu Nutan   +4 more
semanticscholar   +1 more source

Transient cutaneous manifestations after administration of Pfizer‐BioNTech COVID‐19 Vaccine: an Italian single‐centre case series

Journal of the European Academy of Dermatology and Venereology, 2021
Numerous skin manifestations associated with COVID-19 infection have been reported so far1-3 . They include vesicular or maculo-papular skin rashes, livedoid/necrotic lesions, urticaria, chilblains-like lesions and drug induced eruptions1.
M. Corbeddu, A. Diociaiuti, M. Vinci, A. Santoro, V. Camisa, S. Zaffina, M. El Hachem   +6 more
semanticscholar   +1 more source

Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers

European Journal of Pharmaceutical Sciences, 2021
Highlights • Tranexamic acid (TXA) as a treatment for post-partum haemorrhage (PPH) depends on early intervention and rapid systemic exposure.• This study uses PBPK modelling to evaluate the pharmacokinetics of TXA given by different routes of ...
Z. Kane, R. Picetti, Alison J. Wilby, J. Standing, S. Grassin-Delyle, I. Roberts, H. Shakur-Still   +6 more
semanticscholar   +1 more source

Characteristics and application of cutaneous spray preparations in dermal and transdermal drug delivery [PDF]

Arhiv za farmaciju, 2017
Liquid spray preparations for cutaneous administration are solutions, suspensions or emulsions that use compressed or converted gas to a liquid state, to disperse the active substance in the form of aerosols or they are propellant-free (not pressurized ...
Đekić Ljiljana, Pavlović Željko, Primorac Marija   +2 more
doaj   +1 more source

Pretreatmet with 5% lidocaine patch reduces cannula-induced and propofol-induced pain: a randomized, double-blind, placebo-controlled study [PDF]

Korean Journal of Anesthesiology, 2016
BackgroundThe purpose of this study was to determine the efficacy of 5% lidocaine patch in reducing propofol-induced pain and cannula-induced pain.MethodsIn a randomized, double-blind study, 126 patients were divided into one of three groups ...
Jung-Min Hong, Hyeon Jeong Lee, Ah Reum Cho, Ji Seok Baik, Do Won Lee, Young Tae Ji, Ki Chan Yoo, Hae-Kyu Kim   +7 more
doaj   +1 more source

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia

Tropical Medicine and Infectious Disease, 2022
The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administration of pentavalent antimonials that are toxic and poorly tolerated.
Ernesto Rojas Cabrera, Aleida Verduguez-Orellana, Igberto J. Tordoya-Titichoca, Ccoya Sejas, Rebeca Ledezma, Ingrid Álvarez, Jhonny Limachi-Choque, Nimer Ortuño-Gutiérrez, Marisol Córdova Rojas, Miguel Guzman-Rivero   +9 more
doaj   +1 more source

Ethosomes for Coenzyme Q10 Cutaneous Administration: From Design to 3D Skin Tissue Evaluation

Antioxidants, 2020
Ethosome represents a smart transdermal vehicle suitable for solubilization and cutaneous application of drugs. Coenzyme Q10 is an endogenous antioxidant whose supplementation can counteract many cutaneous disorders and pathologies.
Maddalena Sguizzato, P. Mariani, F. Spinozzi, M. Benedusi, F. Cervellati, R. Cortesi, M. Drechsler, R. Prieux, G. Valacchi, E. Esposito   +9 more
semanticscholar   +1 more source

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients

Frontiers in Immunology, 2022
Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogleins. Rituximab effectively treats pemphigus by inducing remission and rapidly reducing corticosteroid dosage.
Ahreum Song, Jieun Jang, Jieun Jang, Ayeong Lee, Seo Yeon Min, Sang Gyun Lee, Soo-Chan Kim, Jaeyong Shin, Jong Hoon Kim   +8 more
doaj   +1 more source

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

Drugs in R&D, 2020
The prevalence of cutaneous adverse events attributable to newly approved anti-cancer drugs has been well reviewed in the dermatologic literature. In contrast, over 75% of US Food and Drug Administration approvals in the past 5 years have been for non ...
Paul C. Macklis, Brittany Dulmage, Brady Evans, Misha Rosenbach, Johann E. Gudjonsson, Benjamin H. Kaffenberger   +5 more
doaj   +1 more source